Reduction in Hospitalizations for Pneumonia Associated With the Introduction of a Pneumococcal Conjugate Vaccination Schedule Without a Booster Dose in Australia | Zendy

Andrew Jardine | Zendy; Robert Menzies | Zendy; Peter McIntyre | Zendy

Open Access

Reduction in Hospitalizations for Pneumonia Associated With the Introduction of a Pneumococcal Conjugate Vaccination Schedule Without a Booster Dose in Australia

Author(s) -

Andrew Jardine,

Robert Menzies,

Peter McIntyre

Publication year - 2010

Publication title -

the pediatric infectious disease journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.028

H-Index - 140

eISSN - 1532-0987

pISSN - 0891-3668

DOI - 10.1097/inf.0b013e3181d7d09c

Subject(s) - medicine , pneumococcal conjugate vaccine , pneumonia , vaccination , booster dose , booster (rocketry) , pediatrics , pneumococcal pneumonia , streptococcus pneumoniae , immunization , immunology , antibiotics , physics , astronomy , antigen , microbiology and biotechnology , biology

Postmarketing surveillance of heptavalent pneumococcal conjugate vaccine (7vPCV) has shown significant reductions in admissions coded as pneumonia in countries where a booster dose is given in the second year of life. In Australia, a 3-dose primary schedule at 2, 4, and 6 months of age without a booster has been funded nationally for non-Indigenous children since 2005.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research